Inject on Thursday instead of the following Monday
Stick to the recommended treatment plan, stay engaged, eat healthy meals, and move your body regularly
Efficacy and safety of once-weekly semaglutide versus once-daily insulin glargine as add-on to metformin (with or without sulfonylureas) in insulin-naive patients with type 2 diabetes (SUSTAIN 4): a randomised, open-label, parallel-group, multicentre, multinational, phase 3a trial
An inulin-propionate ester raised postprandial GLP-1 and PYY and reduced food intake in an overweight-adult randomized controlled trial
We aim to fulfill the unmet needs of medical professionals and patients by developing a patch-type formulation of GLP-1 analogues, which are garnering global attention." About Daewoong Therapeutics Daewoong Therapeutics, a member of the Daewoong Group since February 2019, specializes in R&D for medical and pharmaceutical breakthroughs